A comparative study based on ainuovirine/lamivudine/tenofovir against HIV-1
Therefore, due to its role in immune reconstitution, dyslipidemia, and safety, ANV may be a recommended option for people living with HIV-1.
Authors
- Peipei Luo (ORCID: https://orcid.org/0009-0008-7805-569X)
- Juan Jin
- Haohua Hou
- Yuan Zhang (ORCID: https://orcid.org/0000-0002-4174-0641)
- Jinling Yin (ORCID: https://orcid.org/0000-0003-0309-5327)
- Huanhuan Ba
- Jiajia Li (ORCID: https://orcid.org/0000-0002-1011-4568)
- Xinyan Jing
Institutions
- The Eighth Hospital of Xi'an (CN)
Publication Details
- Journal
- International Journal of STD & AIDS
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1177/09564624241282366
- Citations
- 1
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.39